330 related articles for article (PubMed ID: 27582100)
21. IKKε deficiency inhibits acute lung injury following renal ischemia reperfusion injury.
Meng C; Qian Y; Zhang C; Liu H; Mu X; Zhang A
Mol Med Rep; 2020 Nov; 22(5):4213-4220. PubMed ID: 33000218
[TBL] [Abstract][Full Text] [Related]
22. Knockout of the interleukin-36 receptor protects against renal ischemia-reperfusion injury by reduction of proinflammatory cytokines.
Nishikawa H; Taniguchi Y; Matsumoto T; Arima N; Masaki M; Shimamura Y; Inoue K; Horino T; Fujimoto S; Ohko K; Komatsu T; Udaka K; Sano S; Terada Y
Kidney Int; 2018 Mar; 93(3):599-614. PubMed ID: 29241623
[TBL] [Abstract][Full Text] [Related]
23. Akt1 is involved in tubular apoptosis and inflammatory response during renal ischemia-reperfusion injury.
Kim IY; Park YK; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Mol Biol Rep; 2020 Dec; 47(12):9511-9520. PubMed ID: 33247386
[TBL] [Abstract][Full Text] [Related]
24. RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS.
Yu TM; Palanisamy K; Sun KT; Day YJ; Shu KH; Wang IK; Shyu WC; Chen P; Chen YL; Li CY
Sci Rep; 2016 Jan; 6():18424. PubMed ID: 26725683
[TBL] [Abstract][Full Text] [Related]
25. miR-17-92 ameliorates renal ischemia reperfusion injury.
Song T; Chen M; Rao Z; Qiu Y; Liu J; Jiang Y; Huang Z; Wang X; Lin T
Kaohsiung J Med Sci; 2018 May; 34(5):263-273. PubMed ID: 29699633
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury.
Ascon DB; Lopez-Briones S; Liu M; Ascon M; Savransky V; Colvin RB; Soloski MJ; Rabb H
J Immunol; 2006 Sep; 177(5):3380-7. PubMed ID: 16920979
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury.
O'Neill S; Humphries D; Tse G; Marson LP; Dhaliwal K; Hughes J; Ross JA; Wigmore SJ; Harrison EM
Sci Rep; 2015 Aug; 5():12958. PubMed ID: 26248657
[TBL] [Abstract][Full Text] [Related]
28. The effect of mTOR-inhibition on NF-κB activity in kidney ischemia-reperfusion injury in mice.
Kezic A; Becker JU; Thaiss F
Transplant Proc; 2013 Jun; 45(5):1708-14. PubMed ID: 23769029
[TBL] [Abstract][Full Text] [Related]
29. Protective effect and mechanism of IL-10 on renal ischemia-reperfusion injury.
Sakai K; Nozaki Y; Murao Y; Yano T; Ri J; Niki K; Kinoshita K; Funauchi M; Matsumura I
Lab Invest; 2019 May; 99(5):671-683. PubMed ID: 30700847
[TBL] [Abstract][Full Text] [Related]
30. Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation.
Zhang J; Zhao D; Na N; Li H; Miao B; Hong L; Huang Z
Int J Mol Med; 2018 Jan; 41(1):25-32. PubMed ID: 29115389
[TBL] [Abstract][Full Text] [Related]
31. Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2.
Aleksic T; Baumann B; Wagner M; Adler G; Wirth T; Weber CK
Gut; 2007 Feb; 56(2):227-36. PubMed ID: 16870717
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
Li JH; Tang Y; Lv J; Wang XH; Yang H; Tang PMK; Huang XR; He ZJ; Zhou ZJ; Huang QY; Klug J; Meinhardt A; Fingerle-Rowson G; Xu AP; Zheng ZH; Lan HY
J Cell Mol Med; 2019 Jun; 23(6):3867-3877. PubMed ID: 30968541
[TBL] [Abstract][Full Text] [Related]
33. Effects of kallistatin on oxidative stress and inflammation on renal ischemia-reperfusion injury in mice.
Zhou S; Sun Y; Zhuang Y; Zhao W; Chen Y; Jiang B; Guo C; Zhang Z; Peng H; Chen Y
Curr Vasc Pharmacol; 2015; 13(2):265-73. PubMed ID: 25654330
[TBL] [Abstract][Full Text] [Related]
34. Gal-9/Tim-3 signaling pathway activation suppresses the generation of Th17 cells and promotes the induction of Foxp3
Wang Y; Feng T; Li H; Xiong Y; Tao Y
Mol Immunol; 2023 Apr; 156():136-147. PubMed ID: 36921488
[TBL] [Abstract][Full Text] [Related]
35. NR4A1 silencing protects against renal ischemia-reperfusion injury through activation of the β-catenin signaling pathway in old mice.
Shi W; Dong J; Liang Y; Liu K; Peng Y
Exp Mol Pathol; 2019 Dec; 111():104303. PubMed ID: 31465766
[TBL] [Abstract][Full Text] [Related]
36. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases.
Drube S; Weber F; Göpfert C; Loschinski R; Rothe M; Boelke F; Diamanti MA; Löhn T; Ruth J; Schütz D; Häfner N; Greten FR; Stumm R; Hartmann K; Krämer OH; Dudeck A; Kamradt T
Oncotarget; 2015 Oct; 6(30):28833-50. PubMed ID: 26353931
[TBL] [Abstract][Full Text] [Related]
37. Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production.
Wang B; Wan J; Gong X; Kuang G; Cheng X; Min S
Int Immunopharmacol; 2015 Mar; 25(1):148-54. PubMed ID: 25479719
[TBL] [Abstract][Full Text] [Related]
38. Augmenter of liver regeneration attenuates inflammation of renal ischemia/reperfusion injury through the NF-kappa B pathway in rats.
Yan R; Li Y; Zhang L; Xia N; Liu Q; Sun H; Guo H
Int Urol Nephrol; 2015 May; 47(5):861-8. PubMed ID: 25792007
[TBL] [Abstract][Full Text] [Related]
39. IKappaB-kinase/nuclear factor-kappaB signaling prevents thermal injury-induced gut damage by inhibiting c-Jun NH2-terminal kinase activation.
Chen LW; Chen PH; Chang WJ; Wang JS; Karin M; Hsu CM
Crit Care Med; 2007 May; 35(5):1332-40. PubMed ID: 17414734
[TBL] [Abstract][Full Text] [Related]
40. Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis.
Perez-Nazario N; Rangel-Moreno J; O'Reilly MA; Pasparakis M; Gigliotti F; Wright TW
J Immunol; 2013 Nov; 191(9):4720-30. PubMed ID: 24078701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
